Renaissance Technologies - VIRAX BIOLABS GROUP LTD ownership

VIRAX BIOLABS GROUP LTD's ticker is and the CUSIP is G9495L109. A total of 6 filers reported holding VIRAX BIOLABS GROUP LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of VIRAX BIOLABS GROUP LTD
ValueSharesWeighting
Q2 2023$10
+25.0%
24,600
+115.8%
0.00%
Q4 2022$811,4000.00%
Other shareholders
VIRAX BIOLABS GROUP LTD shareholders Q1 2023
NameSharesValueWeighting ↓
UBS Group AG 147$480.00%
WELLS FARGO & COMPANY/MN 2,000$6500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Citadel Advisors 16,362$5,3180.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,000$4,8750.00%
View complete list of VIRAX BIOLABS GROUP LTD shareholders